Journal of Toxicology

Journal of Toxicology / 2016 / Article

Research Article | Open Access

Volume 2016 |Article ID 4783829 |

Isaac Julius Asiedu-Gyekye, Samuel Frimpong-Manso, Benoit Banga N’guessan, Mahmood Abdulai Seidu, Paul Osei-Prempeh, Daniel Kwaku Boamah, "Macro- and Microelemental Composition and Toxicity of Unsweetened Natural Cocoa Powder in Sprague-Dawley Rats", Journal of Toxicology, vol. 2016, Article ID 4783829, 11 pages, 2016.

Macro- and Microelemental Composition and Toxicity of Unsweetened Natural Cocoa Powder in Sprague-Dawley Rats

Academic Editor: Syed Ali
Received09 May 2016
Revised28 Jun 2016
Accepted10 Jul 2016
Published17 Aug 2016


Unsweetened natural cocoa powder (UNCP) is a pulverized high-grade powder of compressed solid blocks which remains after extraction. Little scientific data is available concerning its safety despite the presence of potential toxic elements. Elemental composition in UNCP was analyzed with ED-XRF spectroscopy. Single oral high dose toxicity study was conducted on adult male Sprague-Dawley rats (150 g) by the limit test method. One group received water and the test group 2000 mg/kg UNCP. All animals were observed for 14 days and then euthanized for haematological, biochemical, and histopathological examinations. Thirty-eight (38) elements were found in UNCP. There was an increase in HDL cholesterol (), reduction in LDL cholesterol (), alkaline phosphatase (), and creatinine levels, and slight increase in urea levels (). Haematological changes were not significant. Histopathological analysis showed no toxic effect on the heart, liver, kidney, lungs, testis, and spleen. Intestinal erosion was observed in the test group. UNCP appears to be relatively safe when taken as a single oral high dose of 2000 mg/kg b.w.t. in rats. Caution should however be exercised at high doses due to the high elemental content of copper and high possibility of intestinal lining erosion.

1. Introduction

Natural products (secondary metabolites) including cocoa have been the most successful source of potential drug leads [1, 2]. Extensive research is being carried out on plant materials gathered from the rain forests and other places for their potential medicinal value and potential toxic effects [3]. As such, the demand for herbal remedies has been increasingly rising in industrialized countries as it is in developing countries [4].

The medicinal and pharmacological importance of Theobroma Cacao and its powder, unsweetened natural cocoa powder (UNCP) as nutraceutical and as traditional medicine, has been well investigated. In Ghana and other parts of Africa, UNCP is used as remedy for managing bronchial asthma, as an aphrodisiac, antidiabetic, anti-inflammatory, cardioprotective, antihypertensive, and antimalarial agent [511]. In Ghana and West Africa, UNCP is a common beverage [1].

Cocoa powder is prepared after removal of the cocoa butter from powdered cocoa beans via fermentation, drying and bagging, winnowing, roasting, grinding, and pressing. The solid blocks of compressed cocoa remaining after extraction (press cake) are pulverised into a fine powder to produce a high-grade cocoa powder.

The chemical composition of cocoa has been well investigated using various methods [1215]. UNCP contains about 1.9% theobromine and 0.21% caffeine [16]. Proanthocyanidin being a constituent of unsweetened natural cocoa powder has been found to be capable of destroying the mucosal lining of the gastrointestinal tract [17]. Besides, micro- and macroelements present in plants may interfere with the availability of secondary metabolites in UNCP which may easily modulate their pharmacological activity [18]. The presence of toxic heavy metals in medicinal plants can also pose as a threat to the health of consumers [19]. For the safety of consumers, the World Health Organization states maximum permissible levels in raw plant materials for only cadmium (0.3 mg k), arsenic (1 mg k), and lead (10 mg k) [20].

Toxicity studies on this nutraceutical are rare. Cocoa per se has not attracted much interest to the scientific world probably because of its long term usage with very little reported adverse effects. There have been reports on the potential carcinogenicity and teratogenicity, that is, bilateral testicular atrophy and aspermatogenesis of cocoa [21, 22]. Besides, Sertoli cells have been identified as the main target for theobromine toxicity accompanying cocoa administration [23].

It is against this background that this study is being conducted to determine the elemental composition and safety of this important nutraceutical.

2. Materials and Methods

2.1. Energy Dispersive X-Ray (ED-XRF) Measurements

Generally, the X-ray fluorescence (XRF) is a fast, accurate, and nondestructive analytical technique used for the elemental and chemical analysis of powdered, solid, and liquid samples [19, 2426].

Sample of processed cocoa powder was purchased (Batch number BT620IT; FDA/DK06-070) from a supermarket. The sample was sieved using sieve of 180 microns. Three samples were prepared and sieved with a mesh size (aperture) of 180 μm into a fine powder and kept in a dry well-labelled container. Before pelletation, the sample was kept in an oven at 60°C overnight. Due to their morphology and the loose nature, triplicate weighed samples—4000 mg/sample—were added separately to 900 mg Fluxana H Elektronic BM-0002-1 (Licowax C micropowder PM-Hoechstwax) as binder; the mixture was homogenized using the RETSCH Mixer Mill (MM301) for 3 min and pressed manually with SPECAC hydraulic press for 2 min with a maximum pressure limit of 15 tons (15000 kg) into pellets of 32 mm in diameter and 3 mm thickness for subsequent XRF measurements. Time between pelletation and measurement was kept short to avoid deformation of the flat surfaces of the pellets. SPECTRO X-Lab 2000 spectrometer (Geological Survey Department, Accra, Ghana) enhanced with three-axial geometry to reduce background noise due to radiation polarization and its monochromatic radiations emitted from the X-ray tube to excite the atoms of the samples were used for simultaneous analysis and measurement of the elemental content of the samples. This spectrometer is equipped with Rh anode and 400 W Pd X-ray tube, a 0.5 mm Be end window tube, a Si (Li) detector (resolution of 148 eV – 1000 cps Mn Kα), available targets (Al2O3 and B4C used as a BARKLA polarizer), HOPG (High Oriented Pyrolitic Graphite) as a BRAGG polarizer, Al, Mo, and Co as secondary target, and 0.5 mm Be side window. It has a carousel (circular rotating sample changer) inside a sample chamber with a capacity of 20 sample holder disc (32 mm) for sequential sample analyses. The radiation chamber was cooled using liquid nitrogen. Its computer-based multichannel analyzer-SPECTRO X-Lab Pro Software package (Turbiquant) controlled and computed spectral analysis and collected, evaluated, and stored data. Combination of these different targets gave a typical detection limit for light elements (Si, Al, Mg, and Na) in the range of 25–50 ppm. For heavy metals, 1–5 ppm was the limit of detection. This spectrometer was factory calibrated using a number of international rock standards.

2.2. Preparation of UNCP

Calculated amount (9.6 g) of Brown Gold Natural Cocoa Powder from Hords Company Ltd., (Batch number BT620IT) registered with the Ghana Food and Drugs Authority (FDA/DK06-070) was dissolved in warm distilled water (40 mL) with stirring making a concentration of 240 mg/mL (of the UNCP). The preparation was then administered to the animals via oral gavage based on their individual body weights.

2.3. Animal Experimentation

Twenty (20) adult male Sprague-Dawley rats of average weight 150 g were purchased from the Animal House Department of the Korle-Bu Teaching Hospital, Korle-Bu, Accra. The rats were acclimatized to laboratory environment (20–24°C), % humidity with a 12 h light-darkness cycle for 7 days prior to experimentation. The rats had access to standard laboratory diet and water ad libitum. The experimental procedures were approved by the departmental ethical and protocol review committee and the Noguchi Memorial Institute for Medical Research Institutional Animal Care and Use Committee with protocol number 2013-01-3E and also conducted in accordance with international ethical guidelines.

2.4. Experimental Design

The Sprague-Dawley rats were randomly assigned to the experimental group and the control group for 7 days before the start of the experiment. Both groups contained ten (10) rats each. All rats had access to water and food except for a 12 hour fasting period before the administration of the unsweetened natural cocoa powder. The experimental group of rats received the unsweetened natural cocoa powder at the dose of 2000 mg/kg while the control group received an equal volume of distilled water. This was based on the fact that the initial testing of 300 mg/kg and 1200 mg/kg to single rats each did not result in any death.

2.5. Effect of UNCP on Body and Relative Organ Weights

Selected organs like the liver, kidney, heart, lungs, testis, spleen, and intestines were excised quickly and placed in ice-cold saline to wash off blood, trimmed of fat and connective tissues, blot dried, and finally weighed on a balance. The organ-to-body weight index (OBI) was calculated as the ratio of organ weight and the body weight of the animal before sacrifice ×100. Body weight of rats were also taken dosing, a week after dosing on Day 7 and before sacrificing them on Day 14.

2.6. Effect of UNCP on Haematological Parameters

Two millilitres (2 mL) of blood from euthanized SD rats was drawn out by cardiac puncture and then transferred into EDTA test tubes. An automated haematology analyzer was used to estimate the counts of the various parameters considered in this study. Peripheral blood smear was also done to examine the nature of blood cells.

2.7. Effect of UNCP on Serum Biochemistry

1 mL of the blood of sacrificed rats was collected by means of cardiac puncture. The blood sample was allowed to stand and then centrifuged at 4000 rpm for 15 minutes using a Wiperfuge centrifuge with the serum collected separately into Eppendoff tubes for the measurement of the biochemical parameters.

2.8. Histopathology Examination

The liver, kidney, heart, lungs, spleen, testis, and small intestinal organs were immediately fixed in 10% buffered formaldehyde solution for 24 h. Samples of the tissues were then paraffin embedded and sectioned at 5 μm thickness. Sectioned tissues were mounted on slides and stained with haematoxylin and eosin (H&E). The sections were evaluated microscopically for histological changes under a light microscope (Olympus BX 51TF).

2.9. Statistical Analysis and Data Evaluation

Statistical analysis of the data was done using GraphPad Prism Software version 5.0. Results were expressed as mean ± standard error of mean, . Significant difference between dosed groups and control was evaluated by performing student’s one-tailed -test. values less than 0.05 were considered statistically significant.

3. Results

3.1. Energy Dispersive X-Ray (ED-XRF) Measurements

A total of thirty-eight (38) macro-12 elements (sodium (Na), magnesium (Mg), aluminium (Al), silicon (Si), phosphorus (P), sulphur (S), chlorine (Cl), potassium (K), calcium (Ca), titanium (Ti), manganese (Mn), and iron (Fe)) and micro-26 elements (vanadium (V), chromium (Cr), cobalt (Co), nickel (Ni), copper (Cu), zinc (Zn), gallium (Ga), arsenic (As), rubidium (Rb), strontium (Sr), yttrium (Y), zirconium (Zr), niobium (Nb), molybdenum (Mo), antimony (Sb), iodine (I), cesium (Cs), barium (Ba), lanthanum (La), cerium (Ce), hafnium (Hf), tantalum (Ta), lead (Pb), bismuth (Bi), thorium (Th), uranium (U)) (Table 1) were identified and evaluated.

mg/4000 mg

MacroelementsNa2.4666 ± 0.00
Mg33.0133 ± 0.02
Al14.0093 ± 0.01
Si15.3880 ± 0.02
P64.3866 ± 0.00
S30.9120 ± 0.00
Cl2.3616 ± 0.00
K149.0667 ± 0.03
Ca11.0146 ± 0.00
Ti0.0232 ± 0.00
Mn0.4093 ± 0.00
Fe1.0309 ± 0.00

MicroelementsV0.2320 ± 1.73
Cr0.4200 ± 17.44
Co0.0108 ± 0.10
Ni0.0638 ± 1.16
Cu0.2984 ± 1.71
Zn0.4086 ± 0.74
Ga0.0024 ± 0.00
As0.0020 ± 0.00
Rb0.1698 ± 0.49
Sr0.1064 ± 0.20
Y0.0016 ± 0.00
Zr0.0125 ± 0.42
Nb0.0070 ± 0.29
Mo0.0044 ± 0.00
Sb0.0043 ± 0.06
I0.0133 ± 0.15
Cs0.0232 ± 0.10
Ba0.0620 ± 5.81
La0.0480 ± 0.00
Ce0.0849 ± 4.97
Hf0.0148 ± 0.17
Ta0.0213 ± 0.06
Pb0.0036 ± 0.00
Bi0.0024 ± 0.00
Th0.0020 ± 0.00
U0.0112 ± 0.10

3.2. Microelements

These elements either in % w/w or in ppm were converted to their respective amounts in milligrams. For example, an average of triplicate measurements of elements such as magnesium (Mg) in percentage was converted as ( 4000 m) and lead (Pb) in parts per million (ppm) was calculated as an average of triplicate measurement:Simple statistics (mean and standard) of the results were calculated to gain a better understanding of the results (Table 1).

3.3. Effects of Treatment on Food, Water Intake, and Body Weight

Food and water intake of the treated animals that received 2000 mg/kg body weight and control group remained relatively the same. There was generally no increase in the intake of food and water by both the control and experimental SD rats. General physical observations such as abnormality of the eyes, skin and fur, coma, convulsion, tremors, diarrhea, lethargy, sleep, morbidity, and then mortality were all not observed to have happened.

From Day 1 to Day 14, there were no significant changes in the body weight of the SD rats that survived at the end of the experiment as in Table 3. However, there was a slight decrease in the weight of the treatment group from Day 1 to Day 14.

3.4. Clinical Signs and Mortality Patterns

At the dose level tested, no untoward clinical signs were observed in all the rats used. There were no changes in the nature of the stool, urine, and an eye colour of all the rats. No mortality was observed in the treatment or control rat groups.

3.5. Effects on Relative Organ Weight

There were no significant changes in the relative weights of the liver, kidney, heart, lungs, spleen, and testis of the treated rats in relation to the control groups. However, the treated rats consistently showed slightly reduced organ weight values as compared to the control group rats. This is as shown in Table 3.

3.6. Effects on Haematological Parameters

There were generally no significant changes in the various haematological parameters of the treatment group in comparison with the control group as shown in Table 3. There was an increased value for the percentage eosinophil and monocyte of the treated group as compared to the control group. This increase was however not statistically significant. Similarly there was a marginal increase for the eosinophil and basophil numbers of the treatment group in comparison with the control group. The platelet number for the treatment groups however reduced in comparison with that of the control group.

The peripheral blood smear also showed no significant changes in the size, colour, and nature of the red blood cells and white blood cells when the treatment group was compared with the control group.

3.7. Effects on Serum Biochemistry

Biochemical profile which includes liver function indices, kidney function indices, and lipid profile of the treated rats and that of the control rats are presented in Table 4.

The acute oral administration of UNCP at the limit dose of 2000 mg/kg body weight did not cause any statistically significant change in the serum proteins and bilirubin as well as some electrolytes (slight decrease in sodium and slight increase in potassium). Blood urea nitrogen increased () while creatinine levels reduced () compared to the control. The levels of the liver marker enzymes (aspartate transaminase, gamma glutamyl transferase, and alanine transferase) of treated animals were not significantly different from that of the control. There was however a reduction in ALP levels (). Changes in serum biochemistry in male SD rats receiving 2000 mg/kg b.w.t. of UNCP are shown in Table 5 and changes in haematological indices in male SD rats receiving 2000 mg/kg b.w.t. of UNCP are shown in Table 6.

3.8. Histopathological Changes
3.8.1. Effects of UNCP Treatment on Histology of the Liver, Kidney, Heart, Lungs, Testis, Spleen, and Small Intestines

The results of histopathology changes in the liver, kidney, heart, lungs, testis, spleen, and small intestines are summarized in Figures 17. The various organs from the control group had a normal histology and appearance. Generally, there were no observable changes in the architecture of the various organs of the treatment rats in comparison with the control.

The histology of the liver and the kidney was consistent with the normal liver and kidney function indices obtained in the serum biochemical analysis. The lipid profile was also consistent with the normal nature of the heart and the liver since both organs had no fatty tissues on observation.

However, the histology of the small intestines of animals that received UNCP showed mild changes as compared to that of the control rats. There were mild erosion of the lining of the small intestines. As such there was only a mild inflammatory response with less cellular infiltration.

4. Discussion

Most people believe that herbal medicines have no side effects or any potential risks due to their natural origins and are often considered as healthy food supplements and not drugs. Most herbs used for medicinal purposes are usually prescribed by the consumers and there is a lack of control and review concerning the dose, frequency, and route of administration. Active components found in these medicinal herbs have the potential of causing toxicity in humans.

This study focused on the acute toxicity effect of UNCP in male SD rats. The increased use of this natural product has called for concerns over both the efficacy and safety of the product.

UNCP contains phytochemicals such as tannins, saponins, cardiac glycosides, terpenoids, and flavonoids [27] which are normally responsible for both therapeutic and toxic effects of various plant and herbal extracts or products [28].

Evaluating UNCP as nutraceutical, the assumption was that the average African weighs 60.70 kg. UNCP will provide the following nutritional values per every 4000 mg of UNCP and its corresponding % RDA as represented in Tables 1 and 2. Magnesium contributes about 25% of the minimum amount of magnesium the human body requires per day (Table 2). Evaluating UNCP’s medicinal value, for example, elements believed to be involved in the pathophysiology of hypertension and dysrhythmias and other cardiovascular diseases [2931], sodium 0.51% (both men and women), magnesium 25% (men) and 32% (women), potassium 10%, and calcium 3%, were considered. High copper 104% (both men and women) and chromium (3750% in men/5250% in women) both implicated in pathophysiology of diabetes further justify cocoa’s traditional usage as traditional medicine.


Na1500 mg1500 mg0.510.51
Mg420 mg320 mg24.6032.30
P700 mg700 mg28.7028.70
Cl2300 mg2300 mg0.320.32
K4700 mg4700 mg10.0010.00
Ca1000 mg1000 mg3.403.40
Mn2.3 mg1.8 mg56.5072.20
Fe8 mg18 mg40.2517.90
Cr35 µg25 µg3750.005250.00
Cu900 µg900 µg103.60103.60
Zn11 mg8 mg11.6016.00
Mo45 µg45 µg30.6030.60
I150 µg150 µg27.7827.78


Day 1112.5 ± 12.50142 ± 8.0000.0526
Day 7115.0 ± 10.00142.0 ± 7.1760.3618
Day 14112.5 ± 7.500135.0 ± 7.0000.0522


Liver8.605 ± 4.2257.454 ± 1.2630.3260
Kidney0.6000 ± 0.050000.5500 ± 0.027390.3618
Heart8.605 ± 4.2257.454 ± 1.2630.3534
Lungs0.8500 ± 0.050000.7600 ± 0.029150.3618
Spleen7.454 ± 1.2630.0829
Testis1.224 ± 0.025020.3618

ParameterUNITSCTRLUNCP value

Creatinineµmol/L43.25 ± 2.92540.61 ± 1.1580.3618
Urea UVmmol/L8.605 ± 4.2258.854 ± 1.2630.2880
Bilirubin totalµmol/L0.795 ± 0.01440.625 ± 0.1650.3960
ALTU/L125 ± 0.722120 ± 5.010.1999
Albuming/L40.5 ± 0.44239.0 ± 0.6920.2046
ASTU/L2.49 ± 0.3582.52 ± 0.5410.3263
Total proteing/L73.1 ± 1.0270.6 ± 3.090.6061
Triglyceridesmmol/L1.28 ± 0.1600.943 ± 0.1160.1185
Bilirubin directµmol/L0.555 ± 0.02401.38 ± 0.4890.1791
ALPU/L707 ± 7.86535 ± 40.70.0103
GGTU/L1.20 ± 0.2002.40 ± 1.440.4316
HDL cholesterolmmol/L0.560 ± 0.03720.755 ± 0.03490.0060
Cholesterolmmol/L2.08 ± 0.08542.15 ± 0.1290.6616
LDL cholesterolmmol/L1.27 ± 0.07400.934 ± 0.1240.0810
Na+mmol/L137 ± 0.479133 ± 0.4770.0002
K+mmol/L5.75 ± 0.1326.44 ± 0.2930.1098
Ca2+mmol/L0.845 ± 0.01320.858 ± 0.01800.5200

ParameterCtrlUNCP value

WBC8.605 ± 4.2257.454 ± 1.2630.3618
Neut. number2.020 ± 0.44001.858 ± 0.38360.4109
Lymph number5.985 ± 3.4354.864 ± 1.1110.3422
Mono. number0.3700 ± 0.2200.3740 ± 0.12250.4936
Eosin. number0.2250 ± 0.1250.3520 ± 0.074390.2045
Baso. number0.0050 ± 0.0050.0060 ± 0.0024490.4228
Neut.%27.65 ± 8.45025.38 ± 4.4500.4021
Lymph.%65.80 ± 7.60063.90 ± 6.1190.4348
Mono.%4.000 ± 0.60005.700 ± 1.6420.2828
Eosin.%2.500 ± 0.20004.940 ± 0.95530.0941
RBC7.360 ± 1.0607.156 ± 0.55330.4290
HGB12.20 ± 1.50012.38 ± 1.0480.4646
HCT36.05 ± 4.05037.82 ± 3.2690.3877
MCV49.20 ± 1.60052.76 ± 0.94050.0515
MCH16.65 ± 0.350017.28 ± 0.23540.1037
MCHC33.80 ± 0.400032.76 ± 0.36960.0862
RDW-CV17.05 ± 3.15015.74 ± 1.1050.3106
RDW-SD27.00 ± 2.00027.70 ± 1.0640.3746
PLT696.5 ± 324.5498.4 ± 166.30.2855

WHO’s permissible limits of lead and arsenic are 0.00016 mg/kg and 0.0010 mg/kg, respectively [32]. Heavy metals determined in UNCP were Pb – 0.0036 mg and As – 0.002 mg corresponding to 0.0002 mg/kg and 0.0001 mg/kg, respectively, with the assumption that the average African weighs 60.7 kg. These values are far below WHO guidelines (Table 2). The high content of Cu2+ (0.2984 mg per 4 g UNCP) should be of concern especially at high doses since copper has been shown to play a role in the pathogenesis of Wilson’s syndrome and liver damage [33, 34] while the high content of chromium could have beneficial effect in the management of diabetes mellitus and cardiovascular disorders [17, 29, 35]. The relationship between these elements, nutrition, and medicine observed suggests that micro- and macroelements of herbal products should not be envisage always as contaminants.

There are concerns however with regard to the copper content in UNCP; with inference from dose translation from animal to human studies according to Reagan-Shaw et al. [36] which takes into account the body surface area of the animal species and man, then (i.e., body weight/surface area) for human adult and rat could be estimated as 37 and 6, respectively [36]. The human equivalent dose (HED) of 2000 mg/kg UNCP in rats corresponds to approximately 324.32 mg/kg HED. This is equivalent to 19,686.224 mg UNCP (approx. 8 teaspoonful if a teaspoonful of UNCP = 2.5 g) for a normal human weight of 60.70 kg. The amount of copper contained in 19,686.224 mg UNCP is 1.469 mg. This may imply that an individual weighing 60.70 kg could have detrimental consequences if 8 teaspoonfuls of UNCP are ingested especially equivalent amounts on a daily basis.

Body weight changes between the control group and the experimental group that were taken on Day 1, Day 7, and Day 14 with respect to dosing were found not to be statistically significant (). The increase in the body weight for both groups for the first week after dosing was about 10 grams (8.3%), which was consistent with other observations [37]. This could be attributed to the increase in the food consumption of the animals within the first week after dosing. There was however a decrease in weight of the SD rats on the 2nd week after dosing by 8.3% and 22.2% () for the control and test group, respectively. The decrease in body weight with the control animals is consistent with the corresponding decrease in their food and water intake while that for the test animals might be explained by the reduction in the food and water intake as well as the ability of UNCP to react with nutrients in the body including stored fat, carbohydrate, and protein [6].

Generally there was a 10.90% () reduction of the organ weight in the test group as compared to the control group. The relative organ weight of the control and experimental group of SD rats was however very similar and thus no significant changes in organ weight were observed.

Hepatic assessment revealed a significant decrease in ALP () and a slight reduction in bilirubin levels () of the UNCP treated group in comparison with the controls. AST and ALT levels were not much affected () by the administration of UNCP solution (Figure 5) as have been observed by other researchers [38, 39]. The plasma protein levels remained relatively unchanged compared with the controls () which may indicate that UNCP has not got any adverse effect on the liver, a situation that is consistent with the histopathological results. It is most likely that the liver being an organ capable of regenerating damaged tissue may not be impaired early following an insult from a toxicant [40].

There was an increase in HDL cholesterol (), a decrease in the level of triglycerides, and LDL cholesterol of the UNCP group () in comparison with that of the control while cholesterol levels remained relatively unchanged (Figure 5). This is consistent with the findings of Hammerstone et al. [41] that flavonoids and procyanidins [17] in UNCP possess lipid lowering abilities. The first human clinical study performed showed that 35 g of delipidated cocoa decreased LDL oxidation between 2 h and 4 h after ingestion [17]. An increase in HDL cholesterol () and reduction in LDL cholesterol of the treated group in comparison with the control group were however recorded which agrees with the work of Galleano et al. [35]. This might possibly explain the antihyperlipidaemic and antihypertensive effect of UNCP observed in other studies [7, 10, 11]. The slight reduction in Na levels supports the diuretic effect of UNCP beneficial in blood pressure control. However, this urine output was not monitored neither did the test animals show significant increase in water consumption. It is highly possible that a much prolonged administration of UNCP could have had significant and pronounced effects on these parameters.

There was a slight increase in the level of urea and K+ () while creatinine levels reduced in the UNCP group as compared to the control group () (Figure 6). Histopathology evaluation of the liver, kidney, heart, lungs, spleen, and the testis of the animals that received UNCP showed no toxic effect as compared to that of the control group. It is obvious that both hepatic and renal effects which showed normal morphology in the treated male SD rats and control are consistent with the results for the kidney and liver function tests. UNCP solution therefore is not likely to have toxic effect on the kidney when administered in a single oral high dose of 2000 mg/kg.

Haematological results showed a decrease (28.44%, ) in the level of platelet in the UNCP group in comparison with the controls. Polyphenols in cocoa have been found to reduce platelet count. Neutrophil and lymphocyte polymorph of white blood cells showed a slight decrease of 8.02% and 18.73%, respectively () (Figure 6). Negligible difference between the experimental and control group was observed in the case of haemoglobin (1.48%) and red blood cells (2.77%, ). These results are contrary to other studies where a forty-eight day administration of an aqueous Venaco cocoa powder was found to increase platelet and white blood cell levels while liver enzymes, HCT, and HGB levels remained relatively unchanged [42]. However, there have been other studies with unexplainable contradictory results where platelets and leucocytes have increased during natural cocoa administration [43, 44]. There remains much investigation into these scientific observations. Besides, there was no significant difference between the actual measurement of the width of the erythrocyte distribution curve and the mean erythrocyte size (RDW-CV and RDW-SD) when compared to the control (). This is confirmed by the peripheral blood smear which showed normal red blood cells with respect to their shape, size, and colour (Figure 1). They were therefore normocytic and normochromic. Thus UNCP is likely not to have produced any toxic effect on the red blood cell, white blood cell, and platelet according to the peripheral blood smear.

One notable effect of UNCP was on the small intestines in the form of erosions of the mucosal lining of the villi, an effect which was not observed in the animals that received equivalent volumes of the vehicle (distilled water) (Figure 8). This could be caused by the high concentration of proanthocyanidins contained in the 2000 mg/kg dose of UNCP (approx. 2.5 g in man). This proanthocyanidins have been found to instigate the destruction of the mucosal lining of the gastrointestinal tract, haemorrhagic gastroenteritis in rabbits, striking lesions in the digestive tract of sheep, and congestion of the intestinal wall in rats [17]. Though considered safe, proanthocyanidin-rich products at high concentrations could result in intestinal erosions. Since the UNCP used in this study is a nonalkalized powder, it is likely to have a greater percentage of total polyphenols, increased epicatechin, and proanthocyanidins as compared to alkalized cocoa powder [45]. This should be a caution for individuals who regularly take high quantities of UNCP as beverage or those with peptic ulcer diseases, since UNCP has some level of cumulative properties.

The morphology of the spleen in the control and the UNCP group also showed normalcy with no tissue necrosis, hyperplasia, or depopulation and thus was concurrent with the results of the haematological analysis.

The lungs, testis, and heart also showed no signs of toxicity in the experimental animals and thus unsweetened natural cocoa powder could be considered to have no toxic effect on these organs at the dose administered in SD rats. In another study, Tarka et al. (1982; 1991) have shown the potential of cocoa to produce teratogenic and reproductive toxicity during chronic administration [21, 22]. This study has attempted to relate the effect of high dose nonalkalized UNCP and its elemental composition in laboratory animals.

5. Conclusion

In conclusion, the aqueous solution of unsweetened natural cocoa powder administered at the single oral high dose of 2000 mg/kg appears to be relatively safe in male SD rats. Caution should however be taken when using UNCP especially in high quantities or amounts since it is capable of causing considerable damage to the mucosal lining of the small intestines.


ED-XRF:Energy dispersive X-ray
RDA:Recommended daily allowance
UNCP:Unsweetened natural cocoa powder
ALT:Alanine aminotransferase
AST:Aspartate aminotransferase
CK:Creatinine kinase
ALP:Alkaline phosphatase
HDL:High density lipoprotein
LDL:Low density lipoprotein
VLDL:Very low density lipoproteins
ANOVA:Analysis of variance
GAFCO:Ghana Agriculture Food Company
Lethal dose
SDR:Sprague-Dawley Rats
HD:High dose
LD:Low dose
LYM%:Lymphocytes percentage
LYM#:Lymphocyte count
MCH:Mean corpuscular haemoglobin
MCHC:Mean corpuscular haemoglobin concentration
MCV:Mean corpuscular volume
MPV:Mean platelet volume
PDW:Platelet distribution width
P-LCR:Platelet larger cell ratio
RBC:Red blood cells
RDW-CV:Coefficient of variation in red cell distribution width
RDW-SD:Standard deviation in red cell distribution width
TP:Total protein
WBC:White blood cells
RDW-SD:Standard deviation in red cell distribution width
RDW-CV:Coefficient of variation in red cell distribution width
PDW:Platelet distribution width
MPV:Mean platelet volume.

Ethical Approval

The study protocol was approved by the departmental ethical and protocol review committee and the Noguchi Memorial Institute for Medical Research Institutional Animal Care and Use Committee with protocol approval number 2013-01-3E.

Competing Interests

The authors hereby declare there are no competing interests in the above research conducted and publication of the paper.


The authors acknowledge the valuable effort of Abraham Terkpertey for the various roles he played as participating investigators in executing this experiment.


  1. F. K. Addai, “Natural cocoa as diet-mediated antimalarial prophylaxis,” Medical Hypotheses, vol. 74, no. 5, pp. 825–830, 2010. View at: Publisher Site | Google Scholar
  2. B. B. Mishra and V. K. Tiwari, “Natural products: an evolving role in future drug discovery,” European Journal of Medicinal Chemistry, vol. 46, no. 10, pp. 4769–4807, 2011. View at: Publisher Site | Google Scholar
  3. G. Kumar, G. S. Banu, P. V. Pappa, M. Sundararajan, and M. R. Pandian, “Hepatoprotective activity of Trianthema portulacastrum L. against paracetamol and thioacetamide intoxication in albino rats,” Journal of Ethnopharmacology, vol. 92, no. 1, pp. 37–40, 2004. View at: Publisher Site | Google Scholar
  4. T. A. Abere, P. E. Okoto, and F. O. Agoreyo, “Antidiarrhoea and toxicological evaluation of the leaf extract of Dissotis rotundifolia triana (Melastomataceae),” BMC Complementary and Alternative Medicine, vol. 10, article 71, 2010. View at: Publisher Site | Google Scholar
  5. T. L. Dillinger, P. Barriga, S. Escárcega, M. Jimenez, D. S. Lowe, and L. E. Grivetti, “Food of the gods: cure for humanity? A cultural history of the medicinal and ritual use of chocolate,” Journal of Nutrition, vol. 130, no. 8, pp. 2057–2072, 2000. View at: Google Scholar
  6. L. Alemanno, T. Ramos, A. Gargadenec, C. Andary, and N. Ferriere, “Localization and identification of phenolic compounds in Theobroma cacao L. somatic embryogenesis,” Annals of Botany, vol. 92, no. 4, pp. 613–623, 2003. View at: Publisher Site | Google Scholar
  7. E. L. Ding, S. M. Hutfless, X. Ding, and S. Girotra, “Chocolate and prevention of cardiovascular disease: a systematic review,” Nutrition & Metabolism, vol. 3, article 2, 2006. View at: Publisher Site | Google Scholar
  8. D. Taubert, R. Berkels, W. Klaus, and R. Roesen, “Nitric oxide formation and corresponding relaxation of porcine coronary arteries induced by plant phenols: essential structural features,” Journal of Cardiovascular Pharmacology, vol. 40, no. 5, pp. 701–713, 2002. View at: Publisher Site | Google Scholar
  9. K. B. Miller, W. J. Hurst, M. J. Payne et al., “Impact of alkalization on the antioxidant and flavanol content of commercial cocoa powders,” Journal of Agricultural and Food Chemistry, vol. 56, no. 18, pp. 8527–8533, 2008. View at: Publisher Site | Google Scholar
  10. I. Andújar, M. C. Recio, R. M. Giner, and J. L. Ríos, “Cocoa polyphenols and their potential benefits for human health,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 906252, 23 pages, 2012. View at: Publisher Site | Google Scholar
  11. S. Arranz, P. Valderas-Martinez, G. Chiva-Blanch et al., “Cardioprotective effects of cocoa: clinical evidence from randomized clinical intervention trials in humans,” Molecular Nutrition & Food Research, vol. 57, no. 6, pp. 936–947, 2013. View at: Publisher Site | Google Scholar
  12. C. Andres-Lacueva, M. Monagas, N. Khan et al., “Flavanol and flavonol contents of cocoa powder products: influence of the manufacturing process,” Journal of Agricultural and Food Chemistry, vol. 56, no. 9, pp. 3111–3117, 2008. View at: Publisher Site | Google Scholar
  13. A. Caligiani, D. Acquotti, M. Cirlini, and G. Palla, “1H NMR study of fermented cocoa (Theobroma cacao L.) beans,” Journal of Agricultural and Food Chemistry, vol. 58, no. 23, pp. 12105–12111, 2010. View at: Publisher Site | Google Scholar
  14. M. Del Rosario Brunetto, L. Gutiérrez, Y. Delgado et al., “Determination of theobromine, theophylline and caffeine in cocoa samples by a high-performance liquid chromatographic method with on-line sample cleanup in a switching-column system,” Food Chemistry, vol. 100, no. 2, pp. 459–467, 2007. View at: Publisher Site | Google Scholar
  15. J. Wollgast and E. Anklam, “Review on polyphenols in Theobroma cacao: changes in composition during the manufacture of chocolate and methodology for identification and quantification,” Food Research International, vol. 33, no. 6, pp. 423–447, 2000. View at: Publisher Site | Google Scholar
  16. C. Awortwe, I. J. Asiedu-Gyekye, E. Nkansah, and S. Adjei, “Unsweetened natural cocoa has anti-asthmatic potential,” International Journal of Immunopathology and Pharmacology, vol. 27, no. 2, pp. 203–212, 2014. View at: Google Scholar
  17. M. Rusconi and A. Conti, “Theobroma cacao L., the food of the gods: a scientific approach beyond myths and claims,” Pharmacological Research, vol. 61, no. 1, pp. 5–13, 2010. View at: Publisher Site | Google Scholar
  18. R. Eyal, “Micro-elements in agriculture,” Practical Hydroponics and Greenhouses, pp. 39–48, 2007. View at: Google Scholar
  19. World Health Organization, Quality Control Methods for Medicinal Plant Materials, WHO Offset Publication, WHO, Geneva, Switzerland, 1998.
  20. J. M. Carvelho, L. G. Ferrerira, P. Amorim, M. L. M. Marques, and M. T. Ramos, “Heavy metals in macrophyte algae using Xray fluorescence,” Environmental Toxicology Chemistry, vol. 16, no. 4, pp. 807–812, 1997. View at: Publisher Site | Google Scholar
  21. S. M. Tarka and H. H. Cornish, “The toxicology of cocoa and methylxanthines: a review of the literature,” CRC Critical Reviews in Toxicology, vol. 9, no. 4, pp. 275–312, 1982. View at: Publisher Site | Google Scholar
  22. S. M. Tarka Jr., R. B. Morrissey, J. L. Apgar, K. A. Hostetler, and C. A. Shively, “Chronic toxicity/carcinogenicity studies of cocoa powder in rats,” Food and Chemical Toxicology, vol. 29, no. 1, pp. 7–19, 1991. View at: Publisher Site | Google Scholar
  23. W. Ying and D. P. Waller, “Theobromine toxicity on Sertoli cells and comparison with cocoa extract in male rats,” Toxicology Letters, vol. 70, no. 2, pp. 155–164, 1994. View at: Publisher Site | Google Scholar
  24. M. J. Anjos, R. T. Lopes, E. F. O. Jesus, S. M. Simabuco, and R. Cesareo, “Quantitative determination of metals in radish using x-ray fluorescence spectrometry,” X-Ray Spectrometry, vol. 31, no. 2, pp. 120–123, 2002. View at: Publisher Site | Google Scholar
  25. C. Vázquez, N. Bárbara, and S. López, “XRF analysis of micronutrients in endive grown on soils with sewage sludge,” X-Ray Spectrometry, vol. 32, no. 1, pp. 57–59, 2003. View at: Publisher Site | Google Scholar
  26. R. E. López De Ruiz, R. A. Olsina, and A. N. Masi, “Different analytical methodologies for the preconcentration and determination of trace chromium by XRF in medicinal herbs with effects on metabolism,” X-Ray Spectrometry, vol. 31, no. 2, pp. 150–153, 2002. View at: Publisher Site | Google Scholar
  27. R. Subhashini, U. S. Mahadeva Rao, P. Sumathi, and G. Gunalan, “A comparative phytochemical analysis of cocoa and green tea,” Indian Journal of Science and Technology, vol. 3, no. 2, pp. 188–192, 2010. View at: Publisher Site | Google Scholar
  28. H. O. Mbagwu, R. A. Anene, and O. O. Adeyemi, “Analgesic, antipyretic and anti-inflammatory properties of Mezoneuron benthamianum Baill (Caesalpiniaceae),” Nigerian Quarterly Journal of Hospital Medicine, vol. 17, no. 1, pp. 35–41, 2007. View at: Google Scholar
  29. H. Nguyen, O. A. Odelola, J. Rangaswami, and A. Amanullah, “A review of nutritional factors in hypertension management,” International Journal of Hypertension, vol. 2013, Article ID 698940, 12 pages, 2013. View at: Publisher Site | Google Scholar
  30. M. Houston, “The role of magnesium in hypertension and cardiovascular disease,” The Journal of Clinical Hypertension, vol. 13, no. 11, pp. 843–847, 2011. View at: Publisher Site | Google Scholar
  31. B. Sontia and R. M. Touyz, “Role of magnesium in hypertension,” Archives of Biochemistry and Biophysics, vol. 458, no. 1, pp. 33–39, 2007. View at: Publisher Site | Google Scholar
  32. R. Masironi, Trace Elements in Relation to cArdiovascular Diseases: Status of the Joint WHO/IAEA Research Programme, WHO Offset Publication, WHO, Geneva, Switzerland, 1973.
  33. O. Bandmann, K. H. Weiss, and S. G. Kaler, “Wilson's disease and other neurological copper disorders,” The Lancet Neurology, vol. 14, no. 1, pp. 103–113, 2015. View at: Publisher Site | Google Scholar
  34. P. Dusek, P. M. Roos, T. Litwin, S. A. Schneider, T. P. Flaten, and J. Aaseth, “The neurotoxicity of iron, copper and manganese in Parkinson's and Wilson's diseases,” Journal of Trace Elements in Medicine and Biology, vol. 31, pp. 193–203, 2015. View at: Publisher Site | Google Scholar
  35. M. Galleano, P. I. Oteiza, and C. G. Fraga, “Cocoa, chocolate, and cardiovascular disease,” Journal of Cardiovascular Pharmacology, vol. 54, no. 6, pp. 483–490, 2009. View at: Publisher Site | Google Scholar
  36. S. Reagan-Shaw, M. Nihal, and N. Ahmad, “Dose translation from animal to human studies revisited,” The FASEB Journal, vol. 22, no. 3, pp. 659–661, 2008. View at: Publisher Site | Google Scholar
  37. Taconic Technical Library, Hematological Clinical Chemistry values Sprague-Dawley Rats, 2003.
  38. C. A. Pieme, V. N. Penlap, B. Nkegoum et al., “Evaluation of acute and subacute toxicities of aqueous ethanolic extract of leaves of Senna alata (L.) Roxb. (Ceasalpiniaceae),” African Journal of Biotechnology, vol. 5, no. 3, pp. 283–289, 2006. View at: Google Scholar
  39. S. K. Ramaiah, “A toxicologist guide to the diagnostic interpretation of hepatic biochemical parameters,” Food and Chemical Toxicology, vol. 45, no. 9, pp. 1551–1557, 2007. View at: Publisher Site | Google Scholar
  40. O. A. Salawu, B. A. Chindo, A. Y. Tijani, I. C. Obidike, and T. A. Salawu, “Acute and sub-acute Toxicological evaluation of the methanolic stem bark extract of Crossopteryx febrifuga in rats,” African Journal of Pharmacy and Pharmacology, vol. 3, pp. 621–626, 2009. View at: Google Scholar
  41. J. F. Hammerstone, S. A. Lazarus, A. E. Mitchell, R. Rucker, and H. H. Schmitz, “Identification of procyanidins in cocoa (Theobroma cacao) and chocolate using high-performance liquid chromatography/mass spectrometry,” Journal of Agricultural and Food Chemistry, vol. 47, no. 2, pp. 490–496, 1999. View at: Publisher Site | Google Scholar
  42. S. Heptinstall, J. May, S. Fox, C. Kwik-Uribe, and L. Zhao, “Cocoa flavanols and platelet and leukocyte function: recent in vitro and ex vivo studies in healthy adults,” Journal of Cardiovascular Pharmacology, vol. 47, no. 2, pp. S197–S205, 2006. View at: Publisher Site | Google Scholar
  43. F. K. Abrokwah, K. A. Asamoah, and P. K. A. Esubonteng, “Effects of the intake of natural cocoa powder on some biochemical and haematological indices in the rat,” Ghana Medical Journal, vol. 43, no. 4, p. 164, 2009. View at: Google Scholar
  44. C. O. Ibegbulem, P. C. Chikezie, and E. C. Dike, “Growth rate, haematologic and atherogenic indicators of rats fed with cocoa beverages,” Journal of Molecular Pathophysiology, vol. 4, no. 2, p. 77, 2015. View at: Publisher Site | Google Scholar
  45. T. H. Stanley, A. T. Smithson, A. P. Neilson, R. C. Anantheswaran, and J. D. Lambert, “Analysis of cocoa proanthocyanidins using reversed phase high-performance liquid chromatography and electrochemical detection: application to studies on the effect of alkaline processing,” Journal of Agricultural and Food Chemistry, vol. 63, no. 25, pp. 5970–5975, 2015. View at: Google Scholar

Copyright © 2016 Isaac Julius Asiedu-Gyekye et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.